Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and In Vitro Characterization

Table 2

Box-Behnken experimental study ().

Runs	GMS/lecithin	Tween 80	Size ()	PDI ()	EE% ()
1	1.25	2.50
2	1.25	4.62
3	0.5	1.00
4	2.31	2.50
5	0.19	2.50
6	2.00	4.00
7	1.25	2.50
8	1.25	2.50
9	2.00	1.00
10	1.25	0.38
11	0.5	4.00